There can be increased likelihood for neonatal encephalopathy when mothers have intrapartum fever. Outcomes
Chorioamnionitis has possible associations with numerous neonatal conditions. Intrapartum (during labor) chorioamnionitis may be associated with neonatal pneumonia, meningitis, sepsis, and death. Long-term infant complications like bronchopulmonary dysplasia, cerebral palsy, and Wilson-Mikity syndrome have been associated to the bacterial infection. Furthermore, histological chorioamnionitis may increase the likelihood of newborn necrotizing enterocolitis, where one or more sections of the bowel die. This occurs when the fetal gut barrier becomes compromised and is more susceptible to conditions like infection and sepsis. In addition, chorioamnionitis can act as a risk factor for premature birth and periventricular leukomalacia. Complications
For mother and fetus, chorioamnionitis may lead to short-term and long-term issues when microbes move to different areas or trigger inflammatory responses due to infection. Maternal complications
Higher risk for C-section
Postpartum hemorrhage
Endometritis
Bacteremia (often due to Group B streptococcus and Escherichia coli)
Pelvic abscessMothers with chorioamnionitis who undergo a C-section may be more likely to develop pelvic abscesses, septic pelvic thrombophlebitis, and infections at the surgical site. Fetal complications
Fetal death
Neonatal sepsis

Neonatal complications
Perinatal death
Asphyxia
Early onset neonatal sepsis
Septic shock
Neonatal pneumonia
Infant respiratory distressIn the long-term, infants may be more likely to experience cerebral palsy or neurodevelopmental disabilities. Disability development is related to the activation of the fetal inflammatory response syndrome (FIRS) when the fetus is exposed to infected amniotic fluid or other foreign entities. This systemic response results in neutrophil and cytokine release that can impair the fetal brain and other vital organs.
Aquaphor is a brand of over-the-counter (OTC) skin care ointments manufactured by Beiersdorf Inc., an affiliate of Beiersdorf AG. Aquaphor is offered in four product ranges:  There are two skin protectant ointments. Aquaphor Original Ointment, used as a compounding agent  and Aquaphor Advanced Therapy Healing Ointment, sold in mass retail outlets. The other product ranges include: Aquaphor Lip Repair and Lip Repair + Protect SPF 30, and Aquaphor Baby. Aquaphor has been  available in the United States market for over 90 years. In accordance with the Food and Drug Administrations OTC Skin Protectant Monograph  Aquaphor, containing 41 percent petrolatum (or petroleum jelly), the active ingredient, temporarily protects minor cuts, scrapes, and burns; protects and helps relieve chapped or cracked skin and lips; helps protect from the drying effects of wind and cold weather.Aquaphor is used and recommended  by health care professionals for minor post-operative wounds or defects. History
1925: Aquaphor was developed in the Beiersdorf Inc laboratories in the USA. It was trademarked that year by Herman A. Metz, president of Beiersdorf Inc at that time. 1929: Beiersdorf sold Aquaphor’s trade marks to Duke Laboratories in order to manufacture products in the country.1936: Aquaphor’s first product offering was sold to doctors, pharmacists and hospitals in 5 lb. containers. 1960: Aquaphor production was discontinued during World War II and restarted by Duke Laboratiories in 1960.